Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 94 entries
View as:

A Study to Evaluate Whether Food Has an Effect on the Uptake of Solifenacin and Tamsulosin When Administered in a Combination Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01953861 Org: User:
Start: 04/30/10 End: 06/30/10 Due: 06/30/11

A Study to Assess the Safety, Tolerability and Effects of Single and Multiple Ascending Doses of ASP1707 in Healthy Male and Pre-menopausal Female Subjects, Including a Comparison of the Effects Under Fasted and Fed Conditions in Healthy Young Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02368912 Org: User:
Start: 06/30/10 End: 08/31/11 Due: 08/31/12

Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity

Phase: N/A Priority: Normal
NCT ID: NCT02751931 Org: User:
Start: 06/17/16 End: 05/06/19 Due: 05/06/20

A Study of ASP8302 in Participants With Underactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT03702777 Org: User:
Start: 11/20/18 End: 04/28/20 Due: 04/28/21

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02127034 Org: User:
Start: 03/31/14 End: 06/30/14 Due: 06/30/15

A Study to Assess the Pharmacokinetics, Metabolism and Excretion Routes of ASP3652 in Man, After Administration of 14C Radio Labeled ASP3652

Phase: N/A Priority: Normal
NCT ID: NCT02046798 Org: User:
Start: 07/31/12 End: 08/31/12 Due: 08/31/13

A Study to Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02161796 Org: User:
Start: 09/30/13 End: 12/31/13 Due: 12/31/14

A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04742517 Org: User:
Start: 11/20/17 End: 09/07/18 Due: 09/07/19

A Study to Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and Tolerability

Phase: N/A Priority: Normal
NCT ID: NCT01958047 Org: User:
Start: 07/31/12 End: 09/30/12 Due: 09/30/13

A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076

Phase: N/A Priority: Normal
NCT ID: NCT01655069 Org: User:
Start: 10/04/12 End: 10/08/14 Due: 10/08/15

A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)

Phase: N/A Priority: Normal
NCT ID: NCT02302079 Org: User:
Start: 01/12/15 End: 08/12/16 Due: 08/12/17

A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02175407 Org: User:
Start: 04/30/14 End: 06/30/14 Due: 06/30/15

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and Elderly Subjects and Healthy Japanese Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03108755 Org: User:
Start: 05/23/17 End: 08/25/17 Due: 08/25/18

First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of Pharmacology

Phase: N/A Priority: Normal
NCT ID: NCT02420782 Org: User:
Start: 05/31/15 End: 05/31/16 Due: 05/31/17

A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy

Phase: N/A Priority: Normal
NCT ID: NCT02788123 Org: User:
Start: 03/03/17 End: 06/13/17 Due: 06/13/18

Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group

Phase: N/A Priority: Normal
NCT ID: NCT01901133 Org: User:
Start: 10/31/11 End: 01/31/12 Due: 01/31/13

Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT01887600 Org: User:
Start: 09/03/13 End: 11/01/17 Due: 11/01/18

A Study to Explore the Routes of Elimination of MDV3100

Phase: N/A Priority: Normal
NCT ID: NCT01911715 Org: User:
Start: 04/30/11 End: 07/31/11 Due: 07/31/12

A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01797198 Org: User:
Start: 04/30/12 End: 06/30/12 Due: 06/30/13

A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02252731 Org: User:
Start: 09/30/13 End: 11/30/13 Due: 11/30/14

An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT02128334 Org: User:
Start: 09/30/13 End: 03/31/16 Due: 03/31/17

A Study to Assess the Effects of Single Ascending Doses of ASP1707 in Healthy Young Japanese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02146742 Org: User:
Start: 06/30/11 End: 08/31/11 Due: 08/31/12

A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis

Phase: N/A Priority: Normal
NCT ID: NCT03282318 Org: User:
Start: 09/28/17 End: 03/21/19 Due: 03/21/20

A Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT02611466 Org: User:
Start: 02/16/16 End: 09/29/17 Due: 09/29/18

This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT01972841 Org: User:
Start: 11/05/13 End: 10/22/15 Due: 10/22/16